Phase I/II trial of Reolysin (reovirus) in combination with carboplatin and paclitaxel in patients with advanced solid tumours (phase 1) and head and neck cancer (phase II).
Phase of Trial: Phase I/II
Latest Information Update: 07 Aug 2014
At a glance
- Drugs Pelareorep (Primary) ; Carboplatin; Paclitaxel
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors Oncolytics Biotech
- 20 Apr 2012 Status changed from active, no longer recruiting to completed based on presented results.
- 07 Jun 2010 Updated survival results presented at the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO-2010)
- 21 May 2010 Results will be presented at ASCO 2010, according to an Oncolytics Biotech media release.